FDA Removes Partial Clinical Hold For Esperion's Drug For Bad Cholesterol
February 03, 2015 at 11:56 AM EST
Shares of Esperion surged as much as 20% on the news that the FDA removed the partial clinical hold for ECT-1002.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.